Article Details

Eli Lilly lines up metabolic pacts with Evotec, Abbisko as it awaits diabetes med nod from FDA

Retrieved on: 2022-01-18 17:49:32

Tags for this article:

Click the tags to see associated articles and topics

Eli Lilly lines up metabolic pacts with Evotec, Abbisko as it awaits diabetes med nod from FDA. View article details on hiswai:

Excerpt

Under the Evotec deal, the biopharma company will look for potential drug candidates and hand off up to five to Lilly. The Big Pharma will then test ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up